Département Inflammation-Immunopathologie-Biothérapie - Hôpital Saint Antoine
- Address
- 184 bd Faubourg Saint Antoine, 75012 Paris, France
Département Inflammation-Immunopathologie-Biothérapie - Hôpital Saint Antoine
The Department of Inflammation-Immunopathology-Biotherapy at Hôpital Saint Antoine is a specialized research center focusing on the intersection of immunological disorders and reproductive health. The department leverages advanced biotherapeutic approaches to address complex conditions where immune dysregulation may contribute to clinical manifestations.
- Recurrent implantation failure and reproductive immunology
- Targeted biologic therapies for immune-mediated conditions
- Anti-TNF therapy applications in unexplained fertility disorders
The center conducts rigorous randomized controlled trials investigating innovative therapeutic interventions for unexplained recurrent implantation failure, exploring how immunomodulatory biotherapies such as certolizumab may improve clinical pregnancy outcomes. This research addresses critical gaps in understanding the role of inflammation and immune factors in reproductive success, offering hope to women experiencing repeated unsuccessful embryo implantation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Département Inflammation-Immunopathologie-Biothérapie - Hôpital Saint Antoine
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy of Certolizumab Pegol in Adult Women with Unexplained Recurrent Implantation Failure: A Double-Blind, Randomized, Placebo-Controlled Trial | Assistance Publique Hopitaux De Paris | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Certolizumab Pegol | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.